Sign In
Buy CSTL
$20.39
+0.680 (+3.45%)
At Close: Jun 03, 2026
Castle Biosciences to Participate in Upcoming Investor Conferences
07:00am, Monday, 28'th Oct 2024
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CastleBiosciences--Castle announces that its executive management is scheduled to present a company overview at three investor conferences in November.
Here's Why Momentum in Castle Biosciences (CSTL) Should Keep going
09:51am, Wednesday, 23'rd Oct 2024
Castle Biosciences (CSTL) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed thr
Castle Biosciences, Inc. (CSTL) is a Great Momentum Stock: Should You Buy?
01:06pm, Tuesday, 22'nd Oct 2024
Does Castle Biosciences, Inc. (CSTL) have what it takes to be a top stock pick for momentum investors? Let's find out.
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #ASDS--Castle will share new data at ASDS supporting the clinical utility of its DecisionDx-Melanoma and DecisionDx-SCC tests.
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CSTL--Castle announced the publication of two recent studies that provide further support for the clinical need of its MyPath® Melanoma GEP test.
Castle Biosciences, Inc. (CSTL) Soars to 52-Week High, Time to Cash Out?
10:22am, Tuesday, 15'th Oct 2024
Castle Biosciences (CSTL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Strength Seen in Castle Biosciences (CSTL): Can Its 9.4% Jump Turn into More Strength?
05:51am, Tuesday, 15'th Oct 2024
Castle Biosciences (CSTL) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price i
Castle Biosciences to Release Third Quarter 2024 Financial Results and Host Conference Call on Monday, Nov. 4, 2024
07:00am, Monday, 14'th Oct 2024
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CastleBiosciences--Castle will release financial results for the third quarter and nine months ended Sept. 30, 2024, after the close of market on Monday,
Castle Biosciences to Support the 71st Annual Montagna Symposium on the Biology of the Skin
07:00am, Friday, 11'th Oct 2024
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CastleBiosciences--Castle will sponsor the 71st Annual Montagna Symposium on the Biology of the Skin, hosted by the OHSU Dept of Dermatology, being held
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #2024SMRCongress--Castle will present new data on DecisionDx-Melanoma and DecisionDx-UM at the 21st International Congress of the Society for Melanoma Res
Castle Biosciences (CSTL) Upgraded to Strong Buy: Here's What You Should Know
01:05pm, Monday, 07'th Oct 2024
Castle Biosciences (CSTL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Castle Biosciences Hosts Groundbreaking Ceremony at Site of New Corporate Headquarters in Friendswood, Texas
07:00am, Wednesday, 02'nd Oct 2024
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CastleBiosciences--The company will hold a groundbreaking ceremony Oct. 22 to celebrate the recent construction start of its new corporate campus and off
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #ASTRO--Castle will share data at ASTRO24 showing its DecisionDx-SCC test can provide impactful risk stratification in high-risk SCC patient sub-populatio
Castle Biosciences: Inflection Into Profitability
06:41am, Friday, 16'th Aug 2024
Castle Biosciences is a fast-growing molecular diagnostics company with a focus on prognostic tests for cancer and mental health patients. The company inflected into net income and operating profitabi
Castle Biosciences, Inc. (CSTL) Q2 2024 Earnings Call Transcript
10:35pm, Monday, 05'th Aug 2024
Castle Biosciences, Inc. (NASDAQ:CSTL ) Q2 2024 Earnings Conference Call August 5, 2024 4:30 PM ET Company Participants Camilla Zuckero - VP, IR & Corporate Affairs Derek Maetzold - Founder, President
